Seattle Genetics, Inc Receives $11,500,000 New Funding

  • Feed Type
  • Date
    6/1/2009
  • Company Name
    Seattle Genetics, Inc
  • Mailing Address
    21823 – 30th Drive S.E. Bothell, WA 98021
  • Company Description
    Seattle Genetics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. Our strategy is to advance our portfolio of product candidates in diseases with unmet medical need and significant market potential. We have more than 250 employees and are located in a high-technology campus in Bothell, Washington, a suburb of Seattle.
  • Website
    http://www.seagen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.